Nathan Collins discusses how the SynFini automated chemistry platform is accelerating drug development and discovery. Learn more about SynFini at: www.sri.com/case-studies/synfini/
Nathan Collins talks about how the SynFini automated chemistry platform is accelerating drug development and discovery.
Read more from SRI
-
The naked mole rat may hold the key to new treatments for neurodegenerative diseases
SRI researchers study the cells of the long-living rodent to find new drug targets for Alzheimer’s, Parkinson’s, and other neurodegenerative disorders.
-
Engineered helper T cell could become a cancer killer
SRI scientists are developing a cell-based platform using an often-undervalued subset of helper T cells to deliver potent antitumor proteins for solid tumors, overcoming dose-related toxicities.
-
SRI spins out Ravenswood Solutions
Ravenswood delivers high-fidelity training experiences to improve military readiness and performance.